Trial Profile
A FEASIBILITY STUDY EVALUATING THE EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR (HCC) CARCINOMA AND HIV INFECTION TREATED WITH HAART REGIMENS.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2012
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Fosamprenavir; HIV protease inhibitors; Ritonavir
- Indications HIV infections; Liver cancer
- Focus Therapeutic Use
- Acronyms Sorafenib-HAART
- 03 Apr 2012 New trial record